We estimated plasma GM-CSF levels in a group of 28 steady-state sickle cell anemia (SS) patients in Kuwait, using an ELISA technique. There were 24 age-matched Hb AA controls, 14 of whom were healthy while 10 were acutely ill at the time of the study. Five SS patients were also studied during 6 episodes of painful crisis. Among the SS patients, 82.1% were homozygous for the Saudi Arabia/India (SAI) haplotype with Hb F ranging from 15 to 35% and total Hb from 8.5 to 11 g/dl. Three patients (siblings) were SAI/Benin compound heterozygotes with Hb F of 9–23% and total Hb >10 g/dl. One patient each was homozygous for the Benin or the Bantu haplotype; they had Hb F <2% and total Hb of 6.6 and 7.2 g/dl, respectively. Four (14.3%) steady-state SS patients had detectable plasma GM-CSF ranging from 75 to 1,817.6 pg/ml. These included the 2 patients with Hb F <2.0% and 2 with the SAI/Benin compound heterozygotes with Hb F of 11 and 9%, respectively. Four (66.7%) SS patients in crisis, 6 (42.9%) healthy controls and 6 (60%) acutely ill controls had detectable plasma GM-CSF. A clearcut association of GM-CSF with Hb F level or degree of anemia in steady-state SS patients could not be established. The appearance of GM-CSF in the plasma of patients in crisis and also among control subjects raises the possibility that other factors are involved in the production of this cytokine in the subjects studied.

Keywords:
GM-CSF, Sickle cell anemia
1.
Powars D, Hiti A: Sickle cell anemia: βS gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child 1993;147:1197–1202.
2.
Nagel RL: Sickle cell anemia is a multigene disease: Sickle painful crises, a case in point. Am J Hematol 1993;42:96–101.
3.
Nagel RL: Severity, pathobiology, epistatic effects and genetic markers in sickle cell anemia. Semin Hematol 1991;28:180–201.
4.
Miller BA, Olivieri N, Salameh M, Ahmed M, Antognetti G, Huisman THJ, Nathan DG, Orkin SH: Molecular analysis of the high hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med 1987;316:244–250.
5.
Adekile AD, Gu L-H, Baysal E, Haider MZ, Al-Fuzae L, Aboobacker KC, Al-Rashied A, Huisman THJ: Molecular characterization of α-thalassaemia determinants, β-thalassaemia alleles and βS haplotypes in Kuwaiti Arabs. Acta Haematol 1994;92:176–181.
6.
Croizat H, Nagel RL: Inhomogeneity of the circulating BFU-E regulation in sickle cell anaemia: Accessory cells properties and BFU-E growth factor response pattern. Br J Haematol 1993;84:481–491.
7.
Owunwanne A, Halkar R, Al-Rashied A, Aboobacker KC, Abdel-Dayem H: Radionuclide imaging of the spleen with heat denatured technetium-99m RBC when the splenic reticuloendothelial system seems impaired. J Nucl Med 1988;29:320–323.
8.
Bissé E, Wieland H: High-performance liquid chromatographic separation of human hemoglobins. Simultaneous quantitation of fetal and glycated hemoglobins. J Chromatogr 1988;434:95–110.
9.
Kutlar A, Kutlar F, Gu L-G, Mayson SM, Huisman THJ: Fetal hemoglobin in normal adults and β-thalassemia heterozygotes. Hum Genet 1990;86:106–110.
10.
Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S: Construction of human gene libraries from small amounts of peripheral blood: Analysis of βS-like globin genes. Hemoglobin 1982;6:27–36.
11.
Lanclos KD, Oner C, Dimovski AL, Gu Y-C, Huisman THJ: Sequence variations of the 5′ flanking and IVS-II regions of the Gγ- and Aγ-globin genes of βS chromosomes with five different haplotypes. Blood 1991;77:2488–2496.
12.
Adekile AD, Gu L-H, Baysal E, Haider MZ, Al-Fuzae L, Aboobacker KC, Al-Rashied A, Huisman THJ: Molecular characterization of α-thalassaemia determinants, β-thalassaemia alleles and βS haplotypes in Kuwaiti Arabs. Acta Haematol 1994;92:171–181.
13.
Baysal E, Huisman THJ: Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol 1994;46:208–213.
14.
Coligan JE, Kruisbeek AM, Margolis DH, Shevach EM, Strober W: Current Protocols in Immunology. Wiley-Green, 1991.
15.
Mishell BB, Shiigi SM: Selected Methods in Cellular Immunology. Reading, Freeman 1980.
16.
Adekile AD, Haider MZ: Morbidity, βS haplotype and α-globin gene patterns in SS patients from Kuwait. Acta Haematol 1996;96:150–154.
17.
Croizat H: Circulating cytokines in sickle cell patients during steady state. Br J Haematol 1994;87:592–597.
18.
Coze CM: Glossary of cytokines. Baillières Clin Haematol 1994;7:1–5.
© 2000 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.